United States: The Supreme Court Tightens Up State-Action Immunity: Justices Rule That Phoebe-Putney/Palmyra Transaction Is Not Immune From Antitrust Scrutiny

Last Updated: March 4 2013
Article by Jay L. Levine and Michael S. Denniston

On February 19, 2013, the Supreme Court unanimously held that the effective acquisition of Palmyra Medical Center (“Palmyra”) by Phoebe Putney Health System, Inc. (“PPHS") in Southwestern Georgia was not immune from antitrust scrutiny, reversing the Eleventh Circuit’s decision to the contrary. In doing so, the Court clarified the standard for qualifying for “state-action immunity” and reinforced the importance of the country’s antitrust law in the hierarchy of competing legal interests.

Background

Georgia’s Hospital Authorities Law allowed municipalities and counties to create a Hospital Authority. The law confers on these municipal authorities 27 enumerated powers, including the power to acquire hospitals and other public health facilities. The Hospital Authority of Albany-Dougherty County (“Authority”) already owned the largest hospital in the county and leased it to a private nonprofit corporation it had formed – PPHS – to manage its operations. In 2010, PPHS proposed to acquire Palmyra, and it structured the transaction such that the Authority purchased Palmyra with PPHS funds and leased it to PPHS. The two hospitals, which are only 2 miles apart, account for 86% of the acute-care hospital services provided to commercial health care plans and their customers in the six counties surrounding Albany.

The FTC filed an administrative complaint alleging that the transaction violates the antitrust laws. It also filed an action in federal district court to enjoin the transaction. The federal district court denied the request for a preliminary injunction and dismissed the case, holding that the transaction was immune from antitrust liability under the “state-action” exemption. That exemption stems from the recognition that the antitrust laws were not meant to restrict a state from regulating its own economy as a sovereign entity. When the act is undertaken by political subdivisions (e.g., county), as opposed to the state itself, the conduct can be exempt, but only when the state has “clearly articulated and affirmatively expressed a state policy to displace competition.” On appeal, the United States Court of Appeals for the Eleventh Circuit affirmed the lower court decision.

Analysis

The case essentially turned on the definition of “foreseeability.” Back in 1985, the Supreme Court held that a state need not explicitly declare that its legislation is intended to have an anticompetitive effect, but rather it was sufficient “if the anticompetitive effect was the “foreseeable result” of what the state authorized.” The Eleventh Circuit defined this as whether the outcome was “reasonably anticipated” by the state legislature. It reasoned that because many markets in Georgia have relatively few hospitals, a hospital acquisition that would lead to a near monopoly was a reasonably foreseeable result of the state’s conferring upon the Authority the power to acquire and lease facilities.

The Supreme Court disagreed, stating that the appellate court “applied the concept of ‘foreseeability’ from our clear-articulation test too loosely.” Rather, foreseeability occurs when the displacement of competition is “the inherent, logical, or ordinary result of the exercise of authority delegated by the state legislature.” As the Court stressed, “simple permission to play in a market” does not “foreseeably entail permission to roughhouse in that market unlawfully.”

The hospitals also argued that given the “unique powers and responsibilities” afforded to hospital authorities to provide adequate and affordable health and hospital care, it was foreseeable that authorities would acquire competing facilities, especially when facing capacity constraints. The Supreme Court rejected this argument as well, holding that nothing in the law clearly articulated a state policy to allow authorities to exercise their general corporate powers without regard to any negative effect on competition. “Particularly in light of our national policy favoring competition, these restrictions should be read to reflect more modest aims.”

Finally, the hospitals argued that any ambiguity regarding whether the clear-articulation test is satisfied should be resolved in favor of finding immunity so as not to improperly interfere with state policy choices. The Supreme Court summarily rejected this argument by stating that it did not find the law ambiguous on this issue. But more importantly, the Court took the opportunity to stress again the importance of the antitrust laws, stating that “federalism and state sovereignty are poorly served by a rule of construction that would allow ‘essential national policies’ embodied in the antitrust laws to be displaced by state delegations of authority intended to achieve more limited ends.” The Supreme Court also pointed out the burden of loosely defining foreseeability. As an amici brief filed by 20 States pointed out, a broad interpretation of the clear articulation test could lead to unintended anticompetitive consequences when state legislatures delegate corporate authority to local bodies. This would require states to disclaim any intent to displace competition to avoid inadvertently authorizing anticompetitive conduct. The Supreme Court flatly stated that, “We decline to set such a trap for unwary state legislatures.”

What this decision means for you

While the Court‘s decision concerns a relatively limited exemption to the antitrust laws, there are three things you should note:

  1. The state-action doctrine comes up in a number of scenarios – both within and outside of healthcare. To the extent that you are involved in a matter where private or municipal actors are claiming to act under a state mandate, the Supreme Court has stiffened the nexus requirement between the allegedly harmful conduct and the articulated state policy.

  2. Structuring a transaction using a governmental authority as a go-between will not likely immunize the transaction from antitrust scrutiny. It is unclear how many parties would actually take advantage of such a transaction structure, but with this decision it is clear that unless the state mandate is very clear, the transaction will get looked at by state or federal regulators.

  3. With the continued desire among providers to integrate and collaborate (e.g. formation of ACOs), coupled with the need for states to establish insurance exchanges, states may well pass legislation incentivizing parties to act in certain ways. Whether healthcare companies of all sorts may point to that legislation for protection from the antitrust laws will now depend on whether the intended conduct is “the inherent, logical, or ordinary result of the exercise of authority delegated by the state legislature.”

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
Kilpatrick Townsend & Stockton LLP
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Kilpatrick Townsend & Stockton LLP
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions